Hildred pursues growth equity investments in lower middle market healthcare companies located in the U.S. and Canada with leading products, technologies and services. Hildred seeks opportunities to create value in healthcare companies with revenues of up to $100 million, from scaling businesses to generate earnings growth, promoting strategic and operational improvements, generating business development, and driving multiple expansion.
The Hildred team brings complementary financial and operating experience and a shared history of working together across the portfolio. The internal Hildred investment team is supported by dedicated Operating Partners, who leverage extensive investing, operating, corporate finance and technology innovation experience, to augment sourcing, due diligence and execution of value creation initiatives across the Fund’s portfolio. The Operating Partners will work closely with the Hildred team and are expected to serve as directors on portfolio company boards and provide hands-on support to management in their respective areas of expertise.
Hildred seeks to make both control and influential minority investments within its target market where the Hildred team and Operating Partners can apply their deep sector knowledge, established reputation in the market, and complementary investment and industry operating experience to enhance growth trajectory and operating efficiency across the Hildred’s portfolio companies. Areas with attractive fundamentals where the Hildred may invest include the following healthcare subsectors: healthcare services, consumer products, information technology, medical devices, and pharmaceuticals.
